The vectors are derived from adeno-associated virus (AAV), and the focus on application is on amyotrophic lateral sclerosis (ALS), aromatic amino acid decarboxylase (ADCC) deficiency. The onset of Parkinson’s disease will also be studied.

Nikkei Biotech news release, September 1, 2016